Terms: = Gastric cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
17 results:
1. Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal cancer.
Booka E; Kikuchi H; Haneda R; Soneda W; Kawata S; Murakami T; Matsumoto T; Hiramatsu Y; Takeuchi H
Anticancer Res; 2022 Jun; 42(6):2977-2987. PubMed ID: 35641297
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of treatment strategies and survival of early-onset gastric cancer: a population-based study.
Zhang C; Tang R; Zhu H; Ge X; Wang Y; Wang X; Miao L
Sci Rep; 2022 Apr; 12(1):6288. PubMed ID: 35428811
[TBL] [Abstract] [Full Text] [Related]
3. A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment.
Liang Z; Huang A; Wang L; Bi J; Kuang B; Xiao Y; Yu D; Hong M; Zhang T
Aging (Albany NY); 2022 Jan; 14(2):907-922. PubMed ID: 35073519
[TBL] [Abstract] [Full Text] [Related]
4. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in gastric cancer.
Li S; Zhao Z; Yang H; Wang D; Sun W; Li S; Zhang Z; Fu W
Cancer Control; 2021; 28():10732748211027160. PubMed ID: 34155937
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score-weighted analysis.
Marqueen KE; Moshier E; Buckstein M; Ang C
Int J Cancer; 2021 Jul; 149(1):177-185. PubMed ID: 33634858
[TBL] [Abstract] [Full Text] [Related]
6. Metformin and Gastrointestinal cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
You JH; Song SO; Kang MJ; Cho YY; Kim SW; Suh SH; Lee S; Lee YH; Lee BW
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00254. PubMed ID: 33105165
[TBL] [Abstract] [Full Text] [Related]
7. Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status.
Chen J; Wang J; Miao Q
Medicine (Baltimore); 2019 Nov; 98(45):e17890. PubMed ID: 31702665
[TBL] [Abstract] [Full Text] [Related]
8. Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery.
Bando E; Makuuchi R; Tokunaga M; Tanizawa Y; Kawamura T; Terashima M
Gastric Cancer; 2017 May; 20(3):448-456. PubMed ID: 27586236
[TBL] [Abstract] [Full Text] [Related]
9. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced gastric Adenocarcinoma.
He B; Zhang HQ; Xiong SP; Lu S; Wan YY; Song RF
Asian Pac J Cancer Prev; 2015; 16(8):3111-6. PubMed ID: 25921105
[TBL] [Abstract] [Full Text] [Related]
10. Cumulative Metformin Use and Its Impact on Survival in gastric cancer Patients After Gastrectomy.
Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
[TBL] [Abstract] [Full Text] [Related]
11. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.
Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A;
Ann Oncol; 2014 Jul; 25(7):1373-1378. PubMed ID: 24728035
[TBL] [Abstract] [Full Text] [Related]
12. Lymph node metastasis in early esophageal adenocarcinoma.
Griffin SM; Burt AD; Jennings NA
Ann Surg; 2011 Nov; 254(5):731-6; discussion 736-7. PubMed ID: 21997815
[TBL] [Abstract] [Full Text] [Related]
13. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract] [Full Text] [Related]
14. [Adjuvant surgery for advanced gastric cancer].
Taomoto J; Tanabe K; Suzuki T; Hamai Y; Emi M; Hihara J; Yoshida K; Okada M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):263-6. PubMed ID: 20154482
[TBL] [Abstract] [Full Text] [Related]
15. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.
Martin RC; Jaques DP; Brennan MF; Karpeh M
Ann Surg; 2002 Aug; 236(2):159-65. PubMed ID: 12170020
[TBL] [Abstract] [Full Text] [Related]
16. [Performance and cost analysis of surgical therapy of stomach carcinoma--results and sequelae].
Mohr VD; Thelen K; Hohenberger W; Zirngibl H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():162-5. PubMed ID: 9101819
[TBL] [Abstract] [Full Text] [Related]
17. Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia.
Barr H; Krasner N
Cancer; 1991 Oct; 68(7):1660-4. PubMed ID: 1716511
[TBL] [Abstract] [Full Text] [Related]
